• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CROs Pharma Start, H2O Clinical to merge

CROs Pharma Start, H2O Clinical to merge

August 15, 2016
CenterWatch Staff

H2O Clinical, based in Hunt Valley, Maryland and Northbrook, Illinois-based Pharma Start, have announced plans to merge. The CROs, which provide a range of outsourced research services to the pharmaceutical industry, already have a history of close collaboration. Each company will continue to operate as it has in the past, and there will be no disruption to current operations or customer contracts. 

The combined companies will provide full-service CRO services in biostatistics, data management, clinical operations and medical writing, as well as other ancillary services to the pharmaceutical, medical device and biotechnology industries.

“H2O and Pharma Start already have a very collaborative relationship,” said Eugenia Henry, president of H2O Clinical. “It made perfect sense to build on this strong and successful relationship by combining forces to grow our businesses in complementary areas.” 

Earl Henry, chief medical officer at H2O Clinical, added, “We’re very excited to offer a full service CRO to the marketplace and our existing clients.”

“The CRO and outsourced pharma contract services market are expected to continue to grow over the next several years,” said Chrissy Fleming, president of Pharma Start. “This growth is a reflection of the ongoing increase in R&D spending around the world and the growth in outsourcing, largely driven by clinical trials becoming more complicated and challenging. Together, Pharma Start and H2O are even more strongly positioned to capitalize on these trends by providing a complete set of premium CRO services to our valued customers.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing